OPKO HEALTH, INC.

For the period ended Mar 31, 2026. Filed Apr 28, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 28, 2026

OPK$1.710.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets as of March 31, 2026

CONDENSED CONSO LIDATED BALANCE SHEET

(In thousands, except share and per share data)

	March 31, 2026	December 31, 2025
ASSETS
Current assets:
Cash, cash equivalents and current restricted cash	$341,881	$369,074
Accounts receivable, net	79,636	90,255
Inventory, net	64,397	65,823
Other current assets and prepaid expenses	49,448	56,729
Total current assets	535,362	581,881
Property, plant and equipment, net	72,585	73,926
Intangible assets, net	496,351	516,276
In-process research and development	195,000	195,000
Goodwill	482,268	484,289
Investments	10,529	14,168
Operating lease right-of-use assets	45,800	46,930
Other assets	18,901	19,474
Total assets	$1,856,796	$1,931,944
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$44,176	$41,103
Accrued expenses	83,476	84,406
Current maturities of operating leases	11,086	10,917
Current portion of lines of credit and notes payable	9,645	10,251
Total current liabilities	148,383	146,677
Operating lease liabilities	35,636	36,815
Long term portion of convertible notes	87,380	85,020
Senior secured royalty financing	246,643	246,433
Deferred tax liabilities	114,562	126,241
Other long-term liabilities	19,582	22,799
Total long-term liabilities	503,803	517,308
Total liabilities	652,186	663,985
Equity:
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 784,892,433 and 789,917,433 shares issued at March 31, 2026 and December 31, 2025, respectively	7,850	7,900
Treasury Stock - 29,799,907, and 30,849,907 shares at March 31, 2026 and December 31, 2025, respectively	(1,791)	(3,176)
Additional paid-in capital	3,571,575	3,574,942
Accumulated other comprehensive loss	(27,486)	(21,017)
Accumulated deficit	(2,345,538)	(2,290,690)
Total shareholders’ equity	1,204,610	1,267,959
Total liabilities and equity	$1,856,796	$1,931,944

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.